Register
Register
Register

ExpertiseUpdated on 2 December 2025

AI-Driven Drug Discovery & Diagnostics: Off-Target Prediction, Medical Imaging & Global Consortium Leadership

Founder and CEO at Yılmaz Bilişim & Assistant Professor at Karadeniz Technical University at Yılmaz Bilişim R&D Consulting Software Engineering and Services Trade Limited Company

Trabzon, Türkiye

About

Yılmaz Bilişim: Computational Expertise for HealthTech R&D

We offer a unique blend of cutting-edge AI research and industrial software engineering, centered around the application of computational methods in life sciences. Our expertise is ready to be deployed in large-scale R&D projects and strategic partnerships.

Core Areas of Expertise:

  • Computational Drug Discovery (In Silico): Specialized in developing AI-based algorithms for early-stage drug development. This includes high-accuracy off-target prediction models to ensure drug safety, as well as virtual screening, molecular docking, and Molecular Dynamics (MD) simulations.

  • Medical Image Processing & AI Diagnostics: Design and implementation of Deep Learning models for automated segmentation and classification of various medical images (e.g., CBCT, Dermoscopy, X-Ray) for enhanced diagnostic support.

  • Advanced Software Solutions: Transforming complex algorithms into stable, commercial R&D software products (e.g., MATS, KATSIMULA).

Strategic Partnership Value:

Our team, led by an Assistant Professor and CEO, possesses strong experience in navigating competitive international funding calls. We are active partners in ERDERA (Rare Diseases) consortia, Türkiye-Hungary Bilateral Cooperation projects, and hold Management Committee (MC) and Working Group (WG) roles in numerous European COST Actions, providing a reliable network and procedural knowledge for project execution.

Field

  • Information Technology & Digital Services

Similar opportunities